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Introduction
Xerostomia is the condition of severe hyposalivation resulting 
from damage of salivary glands from medications, systemic dis-
eases (such as diabetes and Sjögren syndrome), and radiotherapy 
(RT) for head and neck cancer (HNC). More than 30,000 people 
in the United States are diagnosed with HNC annually (1); most 
of these patients receive RT as part of their treatment (2). Despite 
the widespread application of intensity-modulated RT (IMRT) to 
spare the parotid glands during HNC treatment, submandibular 
glands (SMG) are often damaged due to their proximity to the 
regional nodes, which are often involved in HNC. Consequently, 
over 80% of HNC patients treated with RT suffer from xerosto-
mia, which severely impairs their quality of life (3). Current treat-
ment options for RT-related xerostomia are limited and mainly 
focus on temporary symptom improvement (4). Stem cell (SC) 
therapy, in contrast, offers the possibility of permanently restoring 
function of the damaged glands and is therefore more attractive 
than existing therapeutic strategies.
The first cell-surface marker used to isolate putative salivary 
SCs (SSCs) from murine (5) and human SMG (6) was c-Kit. Other 
markers that have been used to identify SSCs include Sca1 (5, 7), 
Thy-1 (8), integrin α6β1, (9, 10), and CD34 (11). The first in vivo 
transplantation assay used murine c-Kit+ cells from SMG. When 
transplanted into irradiated recipient SMGs, c-Kit+ cells partially 
restored the saliva secretion in these mice (5). One major draw-
back of using a single cell-surface marker for SSC identification 
is the large heterogeneity within the isolated cell population due 
to contamination by hematopoietic cells and nonstem epithelial 
cells. Consequently, the purity of isolated SSCs, their optimal func-
tion, and their gene expression remain to be further elucidated.
By including a combination of cell-surface markers to select 
primarily for epithelial SCs while excluding hematopoietic lin-
eages, we were able to obtain a much purer population of SSCs 
from adult mouse SMG. The Lin–CD24+c-Kit+Sca1+–enriched SSCs 
formed the highest number of salispheres as well as the largest and 
the most proliferative spheres in vitro. These cells were capable of 
self renewal and differentiation in vitro. Moreover, transplantation 
of as few as 200 to 300 Lin–CD24+c-Kit+Sca1+ cells into preirradi-
ated SMG successfully enhanced saliva secretion and the number 
of functional acini on serial transplantation studies in vivo.
Improving SC survival while maintaining their regenerative 
properties during serial passaging in vitro and in vivo is a major 
challenge in SC therapy (12). Therefore, it is important to fur-
ther characterize SSCs and identify the critical pathways for their 
survival and stemness. In this study, we also compared the gene 
expression of the Lin–CD24+c-Kit+Sca1+ SSC–enriched population 
to other subpopulations of SMG epithelial cells. We identified glial 
cell line–derived neurotrophic factor (Gdnf) as a gene that is pref-
erentially expressed at high level in SSCs.
GDNF is a member of the GFL family, which also includes 
neurturin (NRTN), artemin (ARTN), and persephin (PSPN) (13, 
14). GDNF has been known to play an important role in neuron 
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Figure 1. Identification of murine SMG SCs. (A) Flow chart of the SSC isolation strategy. FSC, forward scatter; SSC, side scatter; FSH, forward scatter 
height; FSW, forward scatter width; SSH, side scatter height; SSW, side scatter width. (B) Representative sorting plot for SSCs. DAPI negative, single living 
cells were first separated with epithelial marker CD24 and hematopoietic and endothelial lineage marker CD45/31. Lin–CD24hi (P5), Lin–CD24lo (P19), and 
Lin–CD24– (P20) subpopulations were further separated with SC markers c-Kit and Sca1. (C) P7–P18 subpopulations were sorted and cultured on Matrigel. 
Representative growth patterns at D14 in vitro. Scale bar: 100 μm. (D) Quantification of salisphere number to seeding-cell number of each population at D7 
and D14 in vitro. *P < 0.05; **P < 0.01, 1-way ANOVA, compared with P10 Lin–CD24+c-Kit–Sca1– controls. n = 4. Data are presented as mean ± SEM.
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CD24+c-Kit–Sca1– cells (Supplemental Figure 2A). CK5 is a type II 
cytokeratin that forms a heterotetramer with type I CK14. CK5 is 
highly expressed in the embryonic SMG epithelial bud (29), while 
CK14 is a marker of basal layer epidermis (30). In contrast, SSCs 
expressed lower levels of acinar differentiation marker aquapo-
rin 5 (AQP5) compared with control cells. AQP5, a water channel 
protein that plays a major role in saliva production and secretion, 
is only expressed in mature acinar cells (31). The mesenchymal 
marker vimentin was expressed at the same level in both enriched 
and nonenriched SSC populations (Supplemental Figure 2A).
Salispheres from Lin–CD24+c-Kit+Sca1+ SSC–enriched cells 
actively proliferated for at least 14 days in vitro, as indicated by 
Ki67 staining (Figure 2A). In addition, CK5 and CK14 partially 
colocalized in day 7 (D7) and D14 salispheres (Figure 2B). These 
results indicated that Lin–CD24+c-Kit+Sca1+ SSC–enriched cells 
expressed markers of basal layer epithelium and actively prolif-
erated in vitro.
To show that Lin–CD24+c-Kit+Sca1+ SSC–enriched cells could 
differentiate in vitro, we stained the spheres for acinar marker 
AQP5, ductal luminal epithelial marker CK8 (32), and ductal basal 
epithelial marker CK14. AQP5 expression was patchy on D7 and D14 
spheres and became more confluent on D21 spheres (Figure 2C). 
A similar expression pattern was noted for amylase α, which is 
a protein secreted by acinar cells (Figure 2D). CK8 and CK14 
showed partial colocalization in D7 salispheres. CK8 was more 
dominantly expressed in the sphere center at D21, while CK14 was 
highly expressed in the sphere periphery (Figure 2E), a pattern 
that mimics the expression of these 2 cytokeratins in adult SMG. 
In contrast, the SC markers c-Kit, Sca1, and CK14 only partially 
colocalized with the differentiation markers amylase α or AQP5 in 
D21-cultured salispheres (Supplemental Figure 2B).
To prove the self-renewal ability of the SSCs in vitro, D7 sali-
spheres were dissociated into single cells and recultured in Matri-
gel. They were able to form salispheres for at least 3 passages in 
vitro. Salispheres from the third passage continued to express the 
SC markers c-Kit and Sca1 up to D21 in culture (Figure 2F). MTT 
assays indicated that SSC salispheres were actively growing at D14 
in vitro (Supplemental Figure 2C). These findings showed that Lin–
CD24+c-Kit+Sca1+ SSC–enriched cells are capable of self-renewal, 
proliferation, and differentiation in vitro.
SSC transplantation successfully rescues SMG function after 
radiation. To prove that Lin–CD24+c-Kit+Sca1+ SSC–enriched cells 
could proliferate and differentiate in vivo, we injected SSCs iso-
lated from male GFP mice directly into the SMG of the female 
non-GFP recipients. The surface marker profile of SMG cells from 
donor C57BL/6-Tg(UBC-GFP)30Scha/J mice showed a pattern 
similar to that from C57BL/6 mice (Supplemental Figure 3A). The 
GFP+ salisphere count derived from SSCs was also comparable to 
that of C57BL/6 mice (Supplemental Figure 3, B and C). To test 
whether the Lin–CD24+c-Kit+Sca1+ SSC–enriched cells can suc-
cessfully rescue the function of SMG, the recipient mice received 
15 Gy irradiation to the SMG before transplantation. As previously 
reported, 15 Gy irradiation largely destroyed the acini in murine 
SMGs (5, 11). As controls, Lin–CD24+c-Kit–Sca1– cells and unsorted 
bulk SMG cells were transplanted into irradiated SMGs of 2 other 
mouse cohorts. Stimulated saliva secretion was recorded over 
time to evaluate SMG function (Figure 3A).
survival, growth, differentiation, and migration (13, 14). It also par-
ticipates in renal morphogenesis and spermatogenesis by promot-
ing SC self renewal and proliferation (15–17). In addition, GDNF 
is currently being evaluated in the treatment of human Parkinson 
disease in clinical trials, making it a promising candidate for future 
SSC therapy (18, 19). We demonstrated that GDNF treatment in 
vivo either before or after RT improved saliva production in irra-
diated SMGs without accelerating HNC growth. GDNF treatment 
increased the number of surviving SCCs after RT in vivo and 
enhanced salisphere formation in culture. GDNF expression in 
SMG tissues increased with RT and colocalized with that of the 
focal adhesion kinase (FAK) in SSCs. These data together suggest 
that we have identified a highly enriched population of SSCs and 
that GDNF signaling is important for SSC survival and could thus 
be useful in future SC therapies.
Results
Isolation of an enriched population of murine SSCs
Defining the optimal combination of cell-surface markers for murine 
SSC isolation. The steps for SSC enrichment are depicted in Fig-
ure 1A. After removing clumped cells, dead cells, and cell debris, 
we depleted CD45+ and CD31+ hematopoietic and endothelial 
lineage cells (20, 21). We then enriched for epithelial cells with 
CD24 and EpCAM (CD326, a pan-epithelial marker) (22, 23). 
Since all CD24+ cells were EpCAM+, we used CD24 as the epithe-
lial selection marker in subsequent sorting (Supplemental Fig-
ure 1A; supplemental material available online with this article; 
doi:10.1172/JCI74096DS1).
Because c-Kit is a well-known SC marker for many adult tis-
sues (24, 25) and c-Kit+ cells have been shown to improve the func-
tion of irradiated murine SMGs (5), we used c-Kit as our anchor 
SC selection marker. The second SC marker that we selected was 
Sca1, which is an established hematopoietic SC marker (26) and 
was used to identify SSCs in prior studies (5, 7).
We also evaluated CD49f (integrin α6, another putative mark-
er for SSC and breast cancer SC) (8, 22, 27) and CD90.1 (Thy-1, a 
hematopoietic stem marker) (28). Because all CD24+ cells were also 
CD49f+ (Supplemental Figure 1B) and CD90.1+ cells did not improve 
sphere formation over the CD24/c-Kit combination (Supplemental 
Figure 1C), neither marker was used in subsequent sorting.
To evaluate the sphere-forming capacity of the different cell 
subpopulations based on the 4 markers (CD24, c-Kit, Sca1, and lin-
eage markers), we purified cells as depicted in Supplemental Table 1. 
The percentage of each population relative to the parent population 
is also shown in Supplemental Table 1. Representative flow profiles 
are shown in Figure 1B. The highest percentage of c-Kit+Sca1+ cells 
was noted in the CD24+ group (P8) (0.373%). Viable cells from 12 
subpopulations of interest (P7–P18) were cultured in Matrigel. Sev-
eral subpopulations were able to give rise to salispheres (Figure 1C). 
The Lin–CD24+c-Kit+Sca1+ (P8) population yielded the highest sali-
sphere number (Figure 1D); in contrast, Lin–CD24loc-Kit+Sca1+ (P16) 
cells hardly formed any salisphere, indicating SSCs are derived 
mainly from the CD24+ epithelial population.
In vitro characterization of SSCs. Lin–CD24+c-Kit+Sca1+ SSC–
enriched cells expressed higher levels of the SC and basal mark-
ers c-Kit, cytokeratin 5 (CK5), and CK14 compared with the Lin–
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Figure 2. SSCs form salispheres and proliferate and differentiate in vitro. (A) Sorted SSCs grew into salispheres in vitro. Marker Ki67 indicates active 
proliferation. (B) Embryonic SSC marker CK5 and basal epithelial marker CK14 colocalized in D7 salispheres. CK5 and CK14 showed partial colocalization 
in D14 salispheres. (C) Acinar marker AQP5 was expressed in D7, D14, and D21 salispheres. (D) Acinar marker amylase α was expressed in D7, D14, and D21 
salispheres. (E) Luminal epithelial marker CK8 partially colocalized with CK14 in D7 salispheres, but became more concentrated in the center as the spheres 
grew (D21). CK14 was highly expressed in the periphery of the salispheres. (F) D7, D14, and D21 salispheres from the third passages of SSCs all expressed SC 
markers c-Kit and Sca1. Scale bars: 10 μm (D7); 50 μm (D14); 50 μm (D21).
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Figure 3. SSC transplantation successfully rescues SMG function after irradiation. (A) Experiment schema. (B) Total stimulated saliva secretion measured 
before irradiation (basal), 4 weeks after radiation treatment (PRT 4w), and 4, 8 and 12 weeks (PIn 4w, PIn 8w, PIn 12w) after SSC injection in mice receiving 
100 SSCs (n = 7), 200 SSCs (n = 8), 300 SSCs (n = 10), 1,000 SSCs (n = 10), 3,000 Lin–CD24+c-Kit–Sca1– cells (n = 10), and 30,000 unsorted bulk submandibular 
cells (n = 5). *P < 0.05; **P < 0.01, 1-way ANOVA, compared with Lin–CD24+c-Kit–Sca1– control at the same time point. (C) PAS staining of SMG at 13 weeks 
after SSC injection. PAS-positive cells are functional acinar cells. Scale bar: 100 μm. (D) Quantification of the acinar area to total SMG area indicates the 
rescue effect of SSC transplantation. **P < 0.01, 1-way ANOVA, compared with Lin–CD24+c-Kit–Sca1– control, n = 10. Data are presented as mean ± SEM.
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Injection of as few as 200 Lin–GFP+CD24+c-Kit+Sca1+ SSC–
enriched cells partially rescued saliva secretion at 8 weeks after 
transplantation, but the difference did not reach statistical sig-
nificance. Injection of 300 SSCs significantly improved the saliva 
secretion at 8 weeks after transplantation when compared with 
the 3,000 Lin–CD24+c-Kit–Sca1– cells injected in mice at the same 
time point (P < 0.01). Injection of 1,000 SSCs showed an even 
earlier rescue effect seen at 4 weeks after SSC transplantation 
(P < 0.05) (Figure 3B). This dose-response relationship, correlat-
ing the number of SSCs implanted with improved salivary gland 
function, strongly indicates that Lin–GFP+CD24+c-Kit+Sca1+ SSC–
enriched cells were responsible for reconstituting saliva secre-
tion. Based on the flow analysis, the frequency of SSC-enriched 
cells in normal murine SMG was around 0.05% (Figure 1C). The 
number of SSCs in 30,000 unsorted bulk cells was around 15. The 
presence of few SSCs in the unsorted bulk cells likely accounted 
for the partial rescue effect noted at 8 to 12 weeks in this group. 
There was no rescue of saliva secretion in the Lin–CD24+c-Kit–
Sca1– control group (Figure 3B).
PAS staining, which highlights functional acini, confirmed that 
there were more functional acini in SMG transplanted with SSCs 
than with the Lin–CD24+c-Kit–Sca1– (Figure 3C and Supplemental 
Figure 4). Quantification of intact acinar areas (normalized to total 
SMG area) showed approximately 37.6% and 47.5% acini in SMGs 
injected with 300 SSCs and 1,000 SSCs, respectively, compared 
with 16.1% acini in SMGs injected with Lin–CD24+c-Kit–Sca1– con-
Figure 4. SSCs derived from GFP 
donor mice proliferate and dif-
ferentiate in recipient mice. (A) 
Representative flow plot of recipi-
ent SMG at 13 weeks after GFP+ SSC 
injection. GFP donor SSCs differenti-
ated into CD24+ epithelial and CD24lo 
cells as well as c-Kit+Sca1+ SSCs. 
(B) Quantification of percentage 
of GFP+ cells (Lin–GFP+), percent-
age of GFP+ epithelial cells (Lin–
GFP+CD24+), and percentage of GFP+ 
SSCs (Lin–GFP+CD24+c-Kit+Sca1+) in 
viable cells for the different cohorts 
of recipient mice in Figure 3. n = 7, 
8, 8, 9, 9, 5 for different cohorts, 
respectively. *P < 0.05; **P < 0.01, 
1-way ANOVA, compared with 3,000 
Lin–CD24+c-Kit–Sca1– control group 
cells. Data are presented as mean 
± SEM. (C) Immunohistochemical 
staining of GFP in SMG transplanted 
with 3,000 Lin–CD24+c-Kit–Sca1– cells 
or 1,000 SSCs. The magnified views 
are showed correspondingly. Arrows 
point to secretory ducts, and arrow-
heads point to acini. Scale bars:  
200 μm (left, top two panels);  
50 μm (bottom left panel, right 
panels); 10 μm (insets). (D) Immuno-
fluorescent staining of GFP and Sca1 
(red) in SMG transplanted with 1,000 
SSCs. Arrows point to hematopoietic 
cells in a blood vessel adjacent to 
a duct. These cells are positive for 
Sca1 but negative for GFP. Scale bars: 
100 μm (upper panels); 10 μm (lower 
panels). (E) Immunofluorescent 
staining of GFP and CK14 (red) in 
SMG transplanted with 1,000 SSCs. 
Arrowheads point to GFP and CK14 
dual-positive cells located at the 
basal layer of the secretory ducts in 
SMG. Scale bar: 50 μm.
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trol cells (P < 0.01) (Figure 3D). Of note, the percentage of intact 
acinar in unirradiated SMG ranged from 60% to 70%.
Transplanted SSCs proliferate and differentiate in recipient 
murine SMGs. Flow analysis indicated that there were significantly 
more Lin–GFP+ cells in the 1,000 SSC-transplanted group com-
pared with the 3,000 Lin–CD24+c-Kit–Sca1– control group (Figure 4, 
A and B). GFP+ cells from donor mice successfully differentiated 
into Lin–CD24+ cells, Lin–CD24lo cells, and Lin–CD24+c-Kit+Sca1+ 
cells (Figure 4A). The percentages of Lin–CD24+ epithelial and Lin–
CD24+c-Kit+Sca1+ SSC–enriched cells (in viable cells) were signifi-
cantly higher in the 1,000 SSC-transplanted group compared with 
the control group (Figure 4B).
Immunohistochemical (IHC) staining of GFP further con-
firmed that there were more GFP+ cells in the 1,000 SSC-trans-
planted SMG (Figure 4C). Although GFP+ SSCs tended to aggre-
gate around the injection site, we also noted GFP+ cells in regions 
distant from the injection site at 12 weeks after transplantation. The 
multipotency of the SSCs was proved by the fact that GFP+ SSCs 
differentiated into both GFP+ secretory ducts (Figure 4C, arrows) 
and GFP+ acini (Figure 4C, arrowheads) at regions near and far 
from the transplantation site. These results were further confirmed 
by immunofluorescence (IF) staining. A subset of cells expressed 
GFP as well as the SC marker Sca1 (Figure 4D) and basal epithelial 
marker CK14 (Figure 4E, arrowheads), indicating that some GFP+ 
cells maintained SSC features and remained undifferentiated at the 
basal epithelial layer, where SSCs are normally found. Moreover, 
GFP+ SSCs were distinct from endogenous hematopoietic cells, 
which were GFP negative but Sca1 positive (Figure 4D, arrow).
GFP+ SSCs isolated from primary recipients successfully rescue 
SMG function after radiation in secondary recipients. To confirm 
that the Lin–GFP+CD24+c-Kit+Sca1+ SSC–enriched cells could self 
renew in vivo after transplantation into recipient SMGs, we per-
formed a serial transplantation study. GFP+ SSCs were isolated 
from the SMGs of the primary recipients and transplanted into 
irradiated SMGs of the secondary recipients (Figure 3A). 250 Lin–
GFP+CD24+c-Kit+Sca1+ SSC–enriched cells successfully rescued 
saliva secretion in the secondary recipients (Supplemental Figure 
5A). Similar to what was found in the primary recipients, Lin–GFP+ 
cells were able to differentiate into Lin–CD24+, Lin–CD24lo, and 
Lin–CD24+c-Kit+Sca1+ SSC–enriched populations (Supplemental 
Figure 5B). PAS staining confirmed that SMG morphology was 
partially rescued in the secondary recipients (Supplemental Fig-
ure 5C). GFP immunolabeling showed that GFP+ SSCs success-
fully proliferated in the secondary recipients and differentiated 
into secretory ducts (Supplemental Figure 5D, arrows) and acini 
(Supplemental Figure 5D, arrowheads). CK14 expression likewise 
colocalized with GFP in the secretory ducts (Supplemental Figure 
5E, arrowheads). Finally, isolated SSCs from secondary recipients 
were able to grow into salispheres, which expressed SC marker 
Sca1 (Supplemental Figure 5F).
Taken together, these results confirmed that Lin–GFP+CD24+ 
c-Kit+Sca1+ SSCs were able to self renew in vivo in serial transplan-
tation. The progenies derived from GFP+ SSCs were able to prolif-
erate and differentiate in vivo for at least 6 months after the origi-
nal isolation. Based on these data, we believe that we have isolated 
a relatively pure SSC population for further characterization.
Gene-expression analysis of Lin–CD24+c-Kit+Sca1+ SSC-enriched 
population
To investigate the molecular characteristics of SSCs, we performed 
gene-expression analysis of a Lin–CD24+c-Kit+Sca1+ SSC–enriched 
population compared with Lin–CD24+c-Kit–Sca1– cells using the 
Agilent SurePrint G3 Mouse GE microarray platform, which con-
tains 39,430 Entrez Gene RNAs and 16,251 long intergenic non-
coding RNAs (lncRNAs). The 197 genes, which showed more than 
2-fold elevation in the Lin–CD24+c-Kit+Sca1+ SSC–enriched popula-
Table 1. Short list of genes validated by qPCR
Gene symbol Gene name GenBank accession no. Microarray fold change qPCR fold change
Ly6d Lymphocyte antigen 6 complex, locus D NM_010742 4.50 5.94
Wnt10a Wingless related MMTV integration site 10a NM_009518 4.44 3.4
Smr3a Submaxillary gland androgen regulated protein 3A NM_011422 4.20 3.19
Nrxn1 Neurexin I NM_020252 4.10 2.58
Krt17 Keratin 17 NM_010663 3.86 5.62
Krt14 Keratin 14 NM_016958 3.28 5.42
Il18r1 IL-18 receptor 1 NM_008365 3.28 5.58
Ngfr Nerve growth factor receptor (TNFR superfamily, member 16) NM_033217 3.27 5.19
Krt5 Keratin 5 NM_027011 3.18 4.14
Ly6a(Sca1) Lymphocyte antigen 6 complex, locus A NM_010738 3.01 2.95
Camk4 Calcium/calmodulin-dependent protein kinase IV NM_009793 3.00 2.93
Krt15 Keratin 15 NM_008469 2.79 5.03
Fgfr3 FGF receptor 3 NM_008010 2.70 3.92
Aldh3a1 Aldehyde dehydrogenase family 3, subfamily A1 NM_007436 2.50 3.75
Gdnf Glial cell line–derived neurotrophic factor NM_010275 2.33 4.11
Wnt6 Wingless-related MMTV integration site 6 NM_009526 2.14 1.7
Krt8 Mus musculus keratin 8 (Krt8), mRNA [NM_031170] NM_031170 –0.20 0.57
Aqp5 Aquaporin 5 NM_009701 –3.34 –1.5
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tative PCR (qPCR) validation. We focused on the genes in the func-
tional categories of SC markers, epithelial markers, and growth 
factors that showed more than 2-fold elevation in the SSC-enriched 
population. We also included some genes without any change 
(5 genes) or with decreased expression (15 genes) as controls. Out 
of 75 genes, 18 were confirmed with qPCR in 4 independent sam-
ples (Table 1). As expected, the expression of Sca1 and c-Kit was 
tion, can be categorized into 30 groups through the DAVID Func-
tional Annotation. Growth factors closely regulate SC proliferation, 
regeneration, and differentiation. Seven growth factors, Klk1b3, 
Klk1b4, Artn, Ptn, Bmp7, Gdnf, and Cxcl12, had elevated expression 
in the SSC-enriched population (Supplemental Table 2).
To confirm the gene expression profile of the functional catego-
ries with statistical significance, 75 genes were selected for quanti-
Figure 5. GDNF expression in salispheres and SMG tissues. (A) qPCR showed GDNF mRNA was highly expressed in SSCs compared with Lin–CD24+c-Kit–
Sca1– cells. *P < 0.05, t test. n = 3. Data are presented as mean ± SEM. (B) GDNF colocalized with SC marker c-Kit in the salisphere. Scale bar: 10 μm. (C) 
GFRα1 colocalized with basal keratin marker CK14 in the salisphere. Scale bar: 10 μm. (D) GDNF and (E) its receptor GFRα1 were primarily expressed in the 
secretory duct of murine SMG by immunohistochemical staining. Scale bars: 100 μm; 50 μm (insets). (F) GDNF signal was elevated 9 weeks after 15-Gy radia-
tion treatment. Scale bar: 50 μm. (G) GDNF colocalized with NCAM in the ducts after irradiation in human SMG (arrows), but not in the neighboring neurons 
(arrowheads). (H) GDNF colocalized with pFAK in the ducts after irradiation in human SMG (arrows), but not in the neighboring neurons (arrowheads). (I) 
pFAK localized in c-Kit–positive SSCs in the ducts after irradiation in human SMG (arrows). The signals partially overlapped. Scale bar: 10 μm (G–I).
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detected in the ducts and colocalized with both GDNF (Figure 5H, 
arrows) and c-Kit (Figure 5I, arrows) in irradiated SMG tissues. In 
contrast, the downstream target of RET, including phosphor-AKT 
(pAKT) (Supplemental Figure 6F) and phosphor-ERK (pERK) 
(Supplemental Figure 6G) did not colocalize with c-Kit in irradi-
ated SMG tissues. These results indicated that in SSCs, GDNF 
and GFRα1 were likely to function through the interaction with 
the coreceptor NCAM, which then activated FAK after radiation 
damage to the SMG.
GDNF promotes salisphere growth in vitro. To further evaluate 
the role of GDNF in SSCs, we applied GDNF in vitro on SSCs. When 
GDNF (100 ng/ml) was added to SSCs in culture, it significantly 
increased salisphere-forming cell frequency, from 2.7% to 4.0%, 
whereas it had no effect on control Lin–CD24+c-Kit–Sca1– cells (Fig-
ure 6, A and B). In addition, GDNF increased the salisphere num-
ber in a dose-dependent manner (Figure 6C). These data suggest 
that GDNF is a potential growth factor to promote SSC survival.
GDNF successfully rescues SMG after radiation. We investigated 
whether GDNF treatment in vivo would improve saliva produc-
tion in irradiated SMGs. A single dose of 50 μg GDNF was injected 
directly into the SMG of each mouse 24 hours before 15-Gy irradi-
ation. Saliva secretion was measured up to 8 weeks after RT, at the 
time of sacrifice (Figure 6D). When compared with control saline 
injection, a single GDNF injection significantly improved saliva 
production in irradiated mice. The rescue effect was durable, up to 
8 weeks after irradiation, when the mice were euthanized for his-
tological studies (Figure 6E). There was no difference in the body 
weights of GDNF and saline-injected mice, suggesting no systemic 
toxicity. PAS staining revealed more functional and intact acini in 
GDNF-treated SMGs than in saline glands (Figure 6F), translating 
to a larger area of intact acini in GDNF-treated mice (Figure 6G). 
FACS studies also showed significantly more SSCs in GDNF-treat-
ed SMGs compared with saline-treated controls (Figure 6H).
Since GDNF expression is elevated after RT, we also tested 
whether GDNF injection after RT would rescue the saliva produc-
tion (Figure 6D). 50 μg GDNF was injected directly into the SMG 
of each mouse 24 hours after 15 Gy irradiation. GDNF improved 
saliva production after RT (Figure 6I) and increased the percent-
age of functional acini (Figure 6J and Supplemental Figure 7A). 
FACS studies again showed more SSCs in GDNF-treated SMG 
than the saline group (Figure 6K and Supplemental Figure 7B).
GDNF does not function as a radio protector in SMG. To rule out 
the possibility that GDNF acted as a general radiation protector of 
mature salivary cells, we investigated whether GDNF could pro-
tect rat SMG cell line SMG-C6 from radiation-induced cell dam-
age. Clonogenic survival assay showed that GDNF treatment did 
not affect cell survival from radiation treatment (Supplemental 
Figure 8A). ROS generated during irradiation as a result of water 
radiolysis was not changed by GDNF treatment (Supplemen-
tal Figure 8B). The pattern of phosphor-γH2AX after irradiation 
over time, which reflected radiation-induced DNA double-strand 
breaks, was not different with or without GDNF treatment (Sup-
plemental Figure 8C). Although RT induced a G1 arrest in SMG-C6 
cells, there was no difference in the cell-cycle pattern with or with-
out GDNF treatment (Supplemental Figure 8D). These data all 
indicated that GDNF did not act as an overall radio protector in 
mature salivary cells.
higher in SSC than in control cells. The basal keratin markers Krt5, 
Krt15, Krt14 were also highly expressed in SSCs. In contrast, the 
expression of differentiation markers Krt8 and Aqp5 were lower in 
SSC. The Gene Expression Omnibus (GEO) access for the microar-
ray data can be found on NCBI website (GSE46672).
The role of GDNF in SSCs
GDNF expression in salispheres and SMG tissues. Of interest is GDNF, 
which showed a more than 2-fold elevation in SSCs by microarray 
and was 4-fold higher in SSCs by qPCR when compared with the 
Lin–CD24+c-Kit–Sca1– population (Figure 5A). GDNF preferential-
ly binds to the GDNF family receptor α 1 (GFRα1), which mediates 
the activation of the RET receptor tyrosine kinase and functions 
through the PI3K/AKT, MEK/ERK and SRC pathways in neu-
rons (33, 34), ureteric buds (35, 36), and spermatogonial SCs (37). 
Recent studies indicated that the neural cell adhesion molecule 
(NCAM) and the downstream targets FYN/FAK may function as 
alternative pathways for GDNF in regulating axonal guidance and 
corneal regeneration (38–41).
In cultured salispheres, GDNF expression colocalized with 
the SC marker c-Kit (Figure 5B), while GFRα1 colocalized with the 
basal keratin marker CK14 (Figure 5C). In murine SMG tissues, 
GDNF (Figure 5D, arrows) and GFRα1 (Figure 5E) were located at 
the basal layer of the secretory duct epithelium. Similar localiza-
tion was also noted in human SMG (Supplemental Figure 6, A and 
B). Moreover, GDNF expression overlapped with that of GFRα1 in 
mouse SMG (Supplemental Figure 6C). The expression of RET, a 
receptor tyrosine kinase that can be activated upon GDNF’s bind-
ing to GFRα1, was relatively weak and did not show enrichment in 
the ducts (Supplemental Figure 6D). The signal of NCAM, another 
coreceptor, was too weak to be detected in normal SMG tissues.
In irradiated murine and human SMGs, GDNF expression 
was highly upregulated (Figure 5F and Supplemental Figure 6E). 
The coreceptor NCAM became detectable after RT and colocal-
ized with GDNF in the secretary duct (Figure 5G, arrows), but not 
in the neighboring neurons (Figure 5G, arrowheads). Moreover, 
phosphor-FAK (pFAK), the downstream target of NCAM, was also 
Figure 6. GDNF injection successfully rescues radiation-induced SMG 
damage. (A) Treatment with GDNF increased the salisphere number in 
SSCs, but not in Lin–CD24+c-Kit–Sca1– cells. (B) Quantification of salisphere 
number treated with or without GDNF. **P < 0.01, t test, compared with 
nontreated SSCs. SSC (n = 5); Lin–CD24+c-Kit–Sca1– (n = 10). (C) GDNF 
increased salisphere count in a dose-dependent manner. **P < 0.01, t test, 
compared with nontreated SSCs (n = 6). (D) Experimental schema.  
50 μg/mouse GDNF or saline was injected intraglandularly into SMG 1 day 
before (E–H) or after (I–K) 15 Gy radiation of the SMG. (E) Total stimulated 
saliva secretion measured before irradiation (basal), 1, 2, 3, 4, 6, and 8 
weeks after radiation treatment (PRT). n = 10/group. *P < 0.05; **P < 0.01, 
t test. (F) PAS staining of SMG 8 weeks after RT. PAS-positive cells are 
functional acinar cells. Scale bar: 100 μm. (G) Quantification of the acinar 
area to total SMG area indicates the rescue effect of GDNF. **P < 0.01,  
t test. (H) Representative flow plot of SMG at 8 weeks after GDNF/saline 
injection. Quantification of SSC (Lin–CD24+c-Kit+Sca1+) percentage in viable 
cells (DAPI–) indicated that GDNF significantly increased the SSC numbers. 
(n = 7/group) **P < 0.01, t test. (I) Total stimulated saliva secretion. GDNF 
or Saline was injected 1 day after RT (n = 10/group). *P < 0.05; **P < 0.01,  
t test. (J) Quantification of the acinar area to total SMG area. **P < 0.01,  
t test. (K) Quantification of SSC percentage in viable cells (n = 8/group).  
*P < 0.05, t test. All data are presented as mean ± SEM.
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(68), bone marrow (69), and adipose tissue (70). The keratin SC 
markers CK5 and CK14, which are important in maintaining epi-
thelial proliferation (71), are highly expressed in SSCs. Keratin 15 
a SC marker in the hair follicle (72), and keratin 17 could compen-
sate for the loss of CK14 in mouse keratinocytes in maintaining 
cell growth (73). The role of these SSC-enriched genes in SC func-
tion will need further investigation.
Of interest are genes that have not been previously identi-
fied in SSC self renewal. One such genes is Gdnf, which is highly 
expressed in the SSC-enriched population compared with other 
epithelial cells. GDNF is known to play an important role in neu-
ron survival, growth, differentiation, and migration (13, 14) and 
has been implicated in renal morphogenesis and spermatogenesis 
by promoting SC self renewal and proliferation (15–17). Recently, 
a GDNF family member, NRTN, was reported to promote mouse 
embryonic SMG regeneration (74). Our data showed that GDNF 
treatment resulted in enhanced SSC survival and mitigation of RT-
induced functional damage in vivo. Injection of a single dose of 
50 μg GDNF into the SMG either before or after RT significantly 
improved saliva secretion in irradiated mice. The functional res-
cue was associated with a higher SSC yield in vivo when compared 
with saline controls. GDNF also promoted salisphere formation 
of SSCs in vitro in a dose-dependent manner, but did not protect 
differentiated acinar cells from RT damage. Our findings strongly 
support that GDNF did not function as a general radiation protec-
tor, but rather promoted regeneration through SSCs.
GDNF binds to GFRα1, which mediates the activation of 
either the RET receptor tyrosine kinase or the NCAM in neurons. 
RET activates the PI3K/AKT, MEK/ERK, and SRC pathways, and 
NCAM activates the FYN/FAK pathway. Through these down-
stream targets, GDNF prevents apoptosis and promotes prolif-
eration and differentiation in neurons (33, 34, 38–40), ureteric 
bud (35, 36), and spermatogonial SCs (37). Our results show that 
GDNF and its receptor, GFRα1, are found primarily in SSCs, sug-
gesting that GDNF mainly acts as an autocrine factor. The fact that 
radiation increased the expression of GDNF and its colocalization 
with NCAM and pFAK in ductal epithelium suggests that GDNF 
activates the NCAM/FAK pathway in SSCs after RT damage.
ETS transcription factors ETV4 and ETV5 are known down-
stream targets of the GDNF/RET pathway and are involved in 
neuronal development (75), kidney branching (76), and spermato-
genesis (77). In our microarray analysis, Etv4 and Etv5 were not 
upregulated in the SSCs, but 2 other ETV family transcription fac-
tors, Etv6 and Etv1, were found enriched in SSCs. However, neither 
Etv6 nor Etv1 expression showed significant changes in SSCs upon 
GDNF treatment. These data, coupled with the fact that GDNF did 
not colocalize with RET, pAKT, or pERK in either salispheres or 
salivary ductal cells, suggest that the RET signaling pathway may 
not be a significant player in the GDNF pathway in SSC.
Since GDNF is currently being evaluated for the treatment of 
human Parkinson disease in clinical trials (18, 19). The potential 
application of GDNF in improving the survival of SCCs would be 
readily translated to the clinic. Although our results showed that 
GDNF was not a general radiation protector for mature salivary 
cells, whether GDNF primarily promotes SSC survival and prolifera-
tion after radiation or can also promote SSC differentiation remains 
to be further investigated. We have shown that GDNF treatment did 
GDNF treatment did not accelerate HNC growth. In HNC cell 
line SCC 22A, 100 ng/ml GDNF applied 30 minutes before RT 
did not affect clonogenic survival (Supplemental Figure 9A). More 
importantly, intratumor injection of 50 μg GDNF 24 hours after 
12-Gy irradiation to the tumor did not affect the tumor growth 
delay compared with the control (Supplemental Figure 9B). 
These data indicated that GDNF did not modify tumor growth or 
response to irradiation.
Discussion
Repair and reconstitution of adult tissues depends on a small pop-
ulation of SCs. Adult SCs are believed to be quiescent, but become 
activated and drive tissue regeneration upon damage (10, 42, 43). 
There is an increasing interest in SC therapy to restore salivary 
gland function after radiation. SCs from tissues other than salivary 
gland, including bone marrow (7, 44–50), pancreas (51), and lacri-
mal gland (52), have been shown to differentiate into salivary aci-
nar–like structures in vitro, but whether these cells can have acini 
function in vivo remains to be further investigated.
SCs that reside in the salivary microenvironment are pro-
grammed to differentiate into adult glands and are more likely to 
form functional subunits than SCs from other organs. Recently, 
efforts have been made to isolate a pure population of adult SSCs. 
Several single cell-surface markers, including c-Kit (5), Sca1 (5, 7), 
Thy-1 (8), integrin α6β1 (9, 10), and CD34 (11), have been used to 
identify these cells. Although these subpopulations exhibited 
certain SC properties in vitro, only c-Kit–positive cells have been 
transplanted in vivo and could partially rescue saliva function. 
Identification of a pure SSC population will help to reduce the 
number of SSCs required for future therapy and will allow for bet-
ter characterization of these cells.
Here, by using multiple cell-surface markers, we have iden-
tified a highly enriched population of SSCs, as demonstrated by 
their ability to form more spheres and rescue salivary function 
after irradiation in vivo with relatively few cells. More important-
ly, these Lin–CD24+c-Kit+Sca1+ cells can differentiate into duct and 
acinar structures, demonstrating multipotency and self-renewal 
ability both in vitro and in vivo through serial transplantation stud-
ies, up to 6 months after initial isolation.
Several pathways have been implicated in SSC regenera-
tion, proliferation, and differentiation. These include the WNT 
and NOTCH signaling pathways for SC self renewal and lineage 
determination (53–56), ASCL3 for proliferation (57), and GSK3β 
for cell differentiation (58). In addition, the SC niche clearly plays 
an important role in the fate of SCs (59). Many growth factors 
are involved in salivary gland morphogenesis during develop-
ment and regeneration (60), including keratinocyte growth factor 
(KGF, also known as FGF7) (61), FGF10 (62–64), and EGFR (65). 
Our gene-expression analysis of the Lin–CD24+c-Kit+Sca1+ SSC–
enriched population confirmed that several of the genes involved 
in SC self renewal, lineage determination, and development are 
differentially upregulated in these cells. These genes include Wnt 
members Wnt10a and Wnt6, which are involved in osteogenesis 
through a β-catenin–dependent mechanism (66). Wnt6 was also 
implicated in inducing epithelialization of primitive endodermal 
cells (67). Nerve growth factor receptor (NGFR, also known as p75 
and CD271), has been identified as a stem SC marker in neuron 
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transformation was made to the median of all samples and normalized 
to the 75th percentile shift. Genes showing more than 2-fold elevation 
compared with control were further categorized through the DAVID 
Functional Annotation Tool (http://david.abcc.ncifcrf.gov/) following 
instructions. The GEO accession number for microarray data reported 
in this paper is GSE46672.
Salisphere and cell culture. Sorted cells were suspended in DMEM/
F12 medium supplemented with 10% FBS, N2, B27, EGF (20 ng/ml), 
FGF2 (10 ng/ml) and IGF-1 (50 ng/ml), penicillin (100 U/ml), and 
streptomycin (100 mg/ml) (Gibco; Invitrogen), and then plated on 
Matrigel (BD Biosciences) in 96-well plates. Medium change was 
performed every other day. Salisphere numbers were counted on D7 
and D14 of culture.
For in vitro passaging, D7 salispheres were released from Matri-
gel by Dispase (BD Biosciences) treatment for 30 minutes at 37°C, 
followed by 0.25% trypsin/EDTA for 3 minutes at 37°C, then pass-
ing through a 25-gauge needle 3 to 5 times. Single cells were counted 
under microscope and then plated again on a Matrigel 96-well plate.
Rat submandibular epithelial cell line SMG-C6 was obtained from 
Robert Castro (Neonatal and Developmental Medicine, Stanford Uni-
versity) and Margarita M. Vasquez (Neonatal Medicine, University of 
Texas Health Science Center, San Antonio, Texas, USA). Cells were 
cultured in DMEM/F12 medium as previously reported (78).
For additional information, see Supplemental Methods.
Statistics. Data were expressed as SEM. Statistical ANOVA and 
Student’s t tests (2-tailed) were use to compare the data. P ≤ 0.05 is 
considered to be significant.
Study approval. All animal procedures were approved by the Insti-
tutional Animal Care and Use Committee at Stanford University. 
Patient samples were collected via a protocol approved by the Stanford 
Institutional Review Board (IRB #17757).
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not affect radiation response or tumor growth in an HNC cell line. 
However, since GDNF is a growth factor, its effect on promotion of 
salivary cancer development will need to be thoroughly studied.
In summary, we have identified a relatively pure SSC popula-
tion that is capable of self renewal and functional restoration of 
irradiated SMG. We have also identified a growth factor, GDNF, 
that appears to increase the SSC population after radiation treat-
ment and did not promote tumor growth in a HNC cell line. Manip-
ulation of the GDNF pathway may provide a promising avenue for 
future SSC therapy in the clinical setting.
Methods
Animals. C57BL/6 mice and C57BL/6-Tg(UBC-GFP)30Scha/J mice 
were purchased from Jackson Laboratory.
Flow cytometry. SMG tissues were minced and dissociated in 
DMEM/F12 medium (Gibco; Invitrogen) containing collagenase I 
(0.025%), hyaluronidase (0.04%), CaCl2 (6.25 mM), and 25 U/ml dis-
pase (BD Biosciences) for 2 hours at 37°C. The dissociated cells were 
centrifuged at 300 g and filtered through a 400 μm Millipore filter (Mil-
lipore). After the red blood cell lysis, primary SMG cells were incubated 
simultaneously with anti-mouse CD24, CD45, CD31, Sca1 (eBiosci-
ence), and c-Kit antibodies (BD Biosciences) for 30 minutes on ice to 
determine the SC population. Cell viability was detected with DAPI 
(Invitrogen). Cells were sorted on a BD FACS Aria II (BD Biosciences).
Irradiation and intraglandular injection. Six- to eight-week-old 
female C57BL/6 mice were exposed to a single dose of 15 Gy ionized 
irradiation (250k Vp orthovoltage) using the IC-225 Specimen Irra-
diation System (Kimtron Medical). The SMGs were irradiated from 
the lateral side (7.5 Gy per side, total 15 Gy), with the rest of the body 
protected by a lead shield, as previously reported (11). Representative 
photographs of the procedure are shown in Supplemental Figure 10. In 
brief, 4 weeks after irradiation, mice were anesthetized and SMG was 
exposed by small incision. Sorted cells were suspended in 10 μl culture 
medium with 0.5% trypan blue. 5 μl of cells were injected into each side 
of the SMGs using a 10 μl microinjection syringe (Hamilton Co.). The 
skin incision was closed with surgical suture. Then 50 μg/mouse GDNF 
(R&D Systems) was injected through open surgery as described about.
Saliva collection. Saliva was collected for 15 minutes after 2 mg/kg 
pilocarpine injection (s.c.), as previously described (11). The saliva 
flow rate was determined at basal condition, 4 weeks after radiation 
(postradiation treatment [PRT] 4w), and 4, 8, and 12 weeks after cell 
injection (postinjection [PIn] 4w, PIn 8w, and PIn 12w). The measured 
saliva secretion was normalized to the mouse body weight, assuming 
1 g/ml density for saliva.
Microarray and analysis. Total RNA from the sorted cells was 
extracted with RNeasy kit (QIAGEN) following the manufacturer’s 
protocols. Gene expression was determined with Agilent SurePrint G3 
Mouse GE 8x60K arrays (Agilent Technologies) at Stanford Function-
al Genomics Facility and analyzed with GeneSpringGX (Agilent Tech-
nologies). The signal threshold intensity was greater than 5, baseline 
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